Juno vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-08-23
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionJunoIsomorphic Labs
Target UsersChronic illness patientsPharma companies & research institutions
Core FunctionSymptom tracking & doctor reportsAI-driven drug discovery
PricingFreemiumContact sales
AI MethodologyPattern recognition on user logsPredictive & generative models (AlphaFold)
PartnershipsNone (consumer app)J&J, Novartis
Recent FundingNot disclosedSeries B (Feb 2026); $600M raised (2025)

If you're a patient managing a chronic condition, Juno gives you a freemium AI companion to log symptoms and generate doctor-ready reports. If you're a pharma company needing to accelerate drug discovery, Isomorphic Labs offers deep partnerships leveraging AlphaFold—but it's enterprise-only and priced via contact. Choose based on your role: consumer vs. big pharma.

Juno
Juno

AI chronic illness companion for symptom tracking and doctor-ready reports.

Visit Website
Isomorphic Labs
Isomorphic Labs

AI-first drug discovery partner built on Nobel-winning AlphaFold.

Visit Website
Pricing
Freemium
Contact Sales
Plans
Popularity
11 views
7.4k views
Skill Level
Beginner-friendly
Advanced
API Available
Platforms
WebMobile
Categories
🏥 Healthcare🏋️ Fitness & Nutrition
🧬 Drug Discovery & Life Sciences
Features
Customizable symptom tags
Pattern recognition and trend analysis
Automated doctor-ready report generation
Medication and supplement logging
Sleep and activity tracking
Mood and energy level diary
Data export (PDF/CSV)
Secure cloud sync across devices
Reminders for medication and check-ins
AI-generated insights and correlations
Multi-condition support
Daily health summary views
Privacy-first design (GDPR compliant)
Research-backed from Oxford & UCL
Built on Nobel-winning AlphaFold system
Generative AI molecule design via Drug Design Engine
Predictive AI models for protein-ligand interactions
Digital biology simulation at scale
End-to-end drug discovery from target ID to lead optimization
Partnership model with Novartis and Johnson & Johnson
Drug metabolism and toxicity simulation
Bioresilience framework for pandemic preparedness
US operations established in 2025
Series B funding in February 2026
Max Jaderberg appointed as President
Dr. Ben Wolf appointed as Chief Medical Officer
Interdisciplinary team of ML and drug discovery experts

What real users say: Juno vs Isomorphic Labs

Not marketing copy and not our opinion — a structured sweep of public discussion (reviews, forums, communities and video comments), showing what people praise and what they complain about for each tool.

Juno

63 mentions across 3 sources · 7% positive — critical

Hacker News, App Store, Lemmy

What users praise

  • Good community aspect for chronic illness support.
  • Allows tracking of symptoms, meds, sleep, and mood.
  • Helps some users organize health data for doctor visits.
  • Positive initial experience before hitting paywall.

What frustrates them

  • Unable to cancel subscription or delete account easily.
  • App crashes frequently, especially on iPhone 16 Pro.
  • Chat support doesn't work and robo-responses are useless.
  • Free tier runs out of credits almost immediately.

Researched Jul 3, 2026

Isomorphic Labs

48 mentions across 3 sources · 82% positive

Hacker News, YouTube, Lemmy

What users praise

  • Built on the Nobel-winning AlphaFold, giving it instant credibility in structural biology.
  • Drug Design Engine extends beyond structure to generative molecule design, promising novel chemistry.
  • Deep partnerships with Novartis and J&J, with potential billions in royalties.
  • Interdisciplinary team of top ML and drug discovery experts, ensuring depth of expertise.

What frustrates them

  • Not accessible to individual researchers or small biotech due to partnership model only.
  • Proprietary nature of parts of its tech limits community scrutiny and independent validation.
  • CASP16 results suggest AlphaFold 3-based models aren't always better than older methods for protein-ligand interactions.
  • No marketed drugs yet; outcomes remain uncertain with royalties tied to long timelines.

Researched Aug 18, 2026

Who should pick which

  • Chronic illness patient
    Pick: Juno

    Juno offers free symptom tracking, pattern recognition, and doctor report generation—ideal for managing ME/CFS, fibromyalgia, or autoimmune conditions.

  • Pharma VP of Drug Discovery
    Pick: Isomorphic Labs

    Isomorphic Labs provides AI-driven molecular design and simulation via deep partnerships, leveraging AlphaFold to accelerate therapeutic development at scale.

  • Researcher without pharma ties
    Pick: Juno

    Isomorphic Labs is not open to individual researchers; Juno's data export can support research on symptom patterns from user logs.

  • Startup seeking drug repurposing tools
    Pick: Isomorphic Labs

    Only if you can forge a collaboration; otherwise, Juno is irrelevant. Isomorphic Labs works with established pharma, not startups.

  • Patient needing emergency response
    Pick: Juno

    Neither tool suits emergencies, but Juno is the only one that tracks daily health; however, it explicitly does not provide real-time alerts.

Frequently Asked Questions

Juno vs Isomorphic Labs: which should you choose?

If you're a patient managing a chronic condition, Juno gives you a freemium AI companion to log symptoms and generate doctor-ready reports. If you're a pharma company needing to accelerate drug discovery, Isomorphic Labs offers deep partnerships leveraging AlphaFold—but it's enterprise-only and priced via contact. Choose based on your role: consumer vs. big pharma.

Can Juno diagnose my condition?

No. Juno is for tracking symptoms and generating reports for doctors; it does not provide medical advice or diagnosis.

Does Isomorphic Labs sell software licenses?

No. It operates through research collaborations with pharma partners; no API or standalone software is offered.

What is the latest news on Isomorphic Labs?

As of May 2026, it closed a Series B round. In January 2026, it partnered with Johnson & Johnson. It also raised $600M in 2025 and appointed a President and CMO.

Is Juno free?

Juno offers a freemium model; basic tracking and reports are free but premium features may require payment.

Which tool is better for drug discovery?

Isomorphic Labs is purpose-built for drug discovery; Juno is not relevant for that use case.

Can I export my data from Juno?

Yes, Juno allows data export as PDF or CSV.

Who founded Isomorphic Labs?

Sir Demis Hassabis, CEO of DeepMind.

Does Juno integrate with electronic health records?

No, Juno does not integrate with EHR systems.

More Juno or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026